A review on mechanism of action, resistance, synergism, and clinical implications of mupirocin against Staphylococcus aureus

Khoshnood, Saeed; Heidary, Mohsen; Asadi, Arezoo; Soleimani, Saleh; Motahar, Moloudsadat; Savari, Mohammad; Saki, Morteza; Abdi, Mahtab

doi:10.1016/j.biopha.2018.10.131

Cited by 105 publications

(88 citation statements)

References 90 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In our present study, the isolation rates of MuH and MuL were low, namely 4.1% (50/1206) and 1.0% (12/1206), respectively. Recent large studies displayed that the prevalence of MuH is mediated by plasmid-borne mupA gene[22], this is the same as our results. Although mupB, also a plasmid-borne gene, is correlated with MuH[5], this mechanism is rarely examined in staphylococci, including the isolates investigated in the present study.…”

supporting

confidence: 92%

“…No mutations were found in fusE, and no isolates were fusD positive. [22]. In this study, only two MuL isolates (PT300 and wu9) contained the V588F mutation, and no MuL isolates harbored the V631F mutation.…”

Section: Mechanisms Of Fusidic Acid Resistancementioning

confidence: 58%

“…For 3 isolates with resistance to RET, no resistance mechanisms detected in this study were observed.DiscussionMupirocin is effective for the prevention and treatment of MRSA infections. However, the resistance (including MuL) is able to lead to MRSA treatment and eradication failure[22,23]. The prevalence rate of MUP resistance is various in MRSA clinical isolates worldwide, from 0.5-10.1% for MuH and 2.4-8.6% for MuL in America, from 0-75% for MuH and 0%% to 46.7% for MuL in Asia, and from 0.8-98% for MuH and 0-31.2% for MuL in Europe[22].…”

mentioning

confidence: 99%

“…However, the resistance (including MuL) is able to lead to MRSA treatment and eradication failure[22,23]. The prevalence rate of MUP resistance is various in MRSA clinical isolates worldwide, from 0.5-10.1% for MuH and 2.4-8.6% for MuL in America, from 0-75% for MuH and 0%% to 46.7% for MuL in Asia, and from 0.8-98% for MuH and 0-31.2% for MuL in Europe[22]. In our present study, the isolation rates of MuH and MuL were low, namely 4.1% (50/1206) and 1.0% (12/1206), respectively.…”

mentioning

confidence: 99%

See 3 more Smart Citations

Prevalence and molecular characterization of methicillin-resistant Staphylococcus aureus with mupirocin, fusidic acid and/or retapamulin resistance

Chen

Han

et al. 2020

Preprint

View full text Add to dashboard Cite

Abstract Data on the prevalence of resistance to mupirocin (MUP), fusidic acid (FA) and retapamulin (RET) in methicillin-resistant Staphylococcus aureus (MRSA) from China are still limited. In this study we examined these three antibiotics resistance pheno and geno-typically in 1206 MRSA clinical isolates. Phenotypic MUP, FA and RET resistance was determined by MICs, and genotypically by PCR and DNA sequencing examining genes mupA / B , fusB - D , cfr and vgaA / Av , and mutations in ileS , fusA / E , rplC , and 23S RNA V domain. The genetic characteristics of resistance isolates were conducted by PFGE and MLST. Overall MRSA MUP, FA and RET resistance was low (5.1%, 1.0% and 0.3%, respectively). The mupA was the mechanism of high-level MUP resistance. All low-level MUP resistance isolates possessed an equivocal mutation N213D in IleS, and 2 of them additionally had the reported V588F mutation impacting the Rossman fold. FusA mutations, such as L461K, H457Q, H457Y and V90I, were the primary FA resistance mechanisms among high-level resistance isolates, most of which contained fusC ; however, all low-level resistance strains carried fusB . No resistance mechanisms detected were found among RET resistance isolates. Genetic analysis demonstrated clone spread for MUP resistance isolates. In conclusion, MUP, FA and RET exhibited highly activity against MRSA isolates. Acquired genes and chromosome-borne genes mutations were responsible for MUP and FA resistance, and further investigation is needed to uncover the RET resistance mechanisms. Moreover, the surveillance to MUP in MRSA should be strengthened to prevent resistance increase due to the expansion of clones.

show abstract

supporting

confidence: 92%

Section: Mechanisms Of Fusidic Acid Resistancementioning

confidence: 58%

mentioning

confidence: 99%

mentioning

confidence: 99%

See 2 more Smart Citations

Prevalence and molecular characterization of methicillin-resistant Staphylococcus aureus with mupirocin, fusidic acid and/or retapamulin resistance

Chen

Han

et al. 2020

Preprint

View full text Add to dashboard Cite

show abstract

“…Although the mortality rate of MRSA infection has declined in some European countries in recent years, MRSA is still a serious public health challenge worldwide (Rayner and Munckhof, 2005). Due to its characteristics of easy infection, high mortality and multidrug resistance, MRSA has become a stumbling block in clinical treatment (Khoshnood et al, 2019). Hence, how to effectively prevent and control MRSA has become a hot topic in modern research.…”

Section: Concluding Remarkmentioning

confidence: 99%

Prevalence and Therapies of Antibiotic-Resistance in Staphylococcus aureus

Guo

Song

Sun

et al. 2020

Front. Cell. Infect. Microbiol.

551

350

View full text Add to dashboard Cite

Infectious diseases are the second most important cause of human death worldwide; Staphylococcus aureus (S. aureus) is a very common human pathogenic microorganism that can trigger a variety of infectious diseases, such as skin and soft tissue infections, endocarditis, osteomyelitis, bacteremia, and lethal pneumonia. Moreover, according to the sensitivity to antibiotic drugs, S. aureus can be divided into methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA). In recent decades, due to the evolution of bacteria and the abuse of antibiotics, the drug resistance of S. aureus has gradually increased, the infection rate of MRSA has increased worldwide, and the clinical anti-infective treatment for MRSA has become more difficult. Accumulating evidence has demonstrated that the resistance mechanisms of S. aureus are very complex, especially for MRSA, which is resistant to many kinds of antibiotics. Therefore, understanding the drug resistance of MRSA in a timely manner and elucidating its drug resistance mechanism at the molecular level are of great significance for the treatment of S. aureus infection. A large number of researchers believe that analyzing the molecular characteristics of S. aureus can help provide a basis for designing effective prevention and treatment measures against hospital infections caused by S. aureus and further monitor the evolution of S. aureus. This paper reviews the research status of MSSA and MRSA, the detailed mechanisms of the intrinsic antibiotic resistance and the acquired antibiotic resistance, the advanced research on anti-MRSA antibiotics and novel therapeutic strategies for MRSA treatment.

show abstract

Experimental and Computational Studies on Regiodivergent Chiral Phosphoric Acid Catalyzed Cycloisomerization of Mupirocin Methyl Ester

Wang

Argüelles

Tay

et al. 2020

Chemistry A European J

View full text Add to dashboard Cite

This article presents a new strategy for achieving regiocontrol over the endo versus exo modes of cycloisomerizations of epoxide‐containing alcohols, which leads to the formation of five‐ or six‐membered cyclic ethers. Unlike traditional methods relying on achiral reagents or enzymes, this approach utilizes chiral phosphoric acids to catalyze the regiodivergent selective formations of either tetrahydrofuran‐ or tetrahydropyran‐containing products. By using methyl ester of epoxide‐containing antibiotic mupirocin as the substrate, it is demonstrated that catalytic chiral phosphoric acids (R)‐TCYP and (S)‐TIPSY could be used to achieve the selective formation of either the six‐membered endo product (95:5 r.r.) or the five‐membered exo product (77:23 r.r.), correspondingly. This cyclization was found to be unselective under the standard conditions involving various achiral acids, bases, or buffers. The subsequent mechanistic studies using state‐of‐the‐art quantum chemical solutions provided the description of the potential energy surface, which is fully consistent with the experimental observations. Based on these results, highly detailed reaction paths are obtained and a concerted and highly synchronous mechanism is proposed for the formation of both exo and endo products.

show abstract

A review on mechanism of action, resistance, synergism, and clinical implications of mupirocin against Staphylococcus aureus

Cited by 105 publications

References 90 publications

Prevalence and molecular characterization of methicillin-resistant Staphylococcus aureus with mupirocin, fusidic acid and/or retapamulin resistance

Prevalence and molecular characterization of methicillin-resistant Staphylococcus aureus with mupirocin, fusidic acid and/or retapamulin resistance

Prevalence and Therapies of Antibiotic-Resistance in Staphylococcus aureus

Experimental and Computational Studies on Regiodivergent Chiral Phosphoric Acid Catalyzed Cycloisomerization of Mupirocin Methyl Ester

Contact Info

Product

Resources

About